Search - tctmd.com

Displaying 1 - 20 of 106

Sort: Relevancy | Date

Presentation TCT 2025

Viewpoint 2: When to do T-TEER or TTVR

Presenter: Paul Sorajja

October 28, 2025

Presentation TCT 2025

An Innovative Tricuspid Therapy: Introducing the TripairTM Technology (Coramaze)

Presenter: Paul Sorajja

October 27, 2025

Presentation TCT 2025

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Presenter: Paul Sorajja

October 27, 2025

Presentation NY Valves 2025

Electrosurgery Clip Removal Followed by TMVR

Presenter: Paul Sorajja

June 27, 2025

Presentation NY Valves 2025

Viewpoint 2: When to do Tricuspid TEER

Presenter: Paul Sorajja

June 27, 2025

Presentation NY Valves 2025

The TriPair Tricuspid Repair Solution (Coramaze)

Presenter: Paul Sorajja

June 26, 2025

Presentation NY Valves 2025

Transcatheter Treatment After TEER — Lacerate or Remove?

Presenter: Paul Sorajja

June 26, 2025

Presentation NY Valves 2025

YES, in these Desperate Patients, Quality-of-Life Outcomes Are a Great Starting Point!

Presenter: Paul Sorajja

June 26, 2025

Presentation NY Valves 2025

Performance of Atrial-fixation TMVR in Patients With Mitral Regurgitation (MR) and Mitral Annular Calcification (MAC)

Presenter: Paul Sorajja

June 25, 2025

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

The Interventional Cardiologist’s Perspective: Which Primary MR Patients Should Be Referred For Surgery?

Presenter: Paul Sorajja

October 29, 2024

Presentation TCT 2024

The Role of TMVR With Dedicated Devices in Patients With MAC: Initial Results and Ongoing Trials

Presenter: Paul Sorajja

October 29, 2024

Presentation TCT 2024

Procedural Goals for TTVI - Is Moderate TR Good Enough?

Presenter: Paul Sorajja

October 29, 2024

Presentation TCT 2024

Novel Technology to Enable Atrioventricular Valve Replacement After TEER Therapy (AMX Technologies) (68998)

Presenter: Paul Sorajja

October 27, 2024

Presentation TCT 2023

Pre-Clinical Results With A Chronically-Adjustable And Pressure Sensing Interatrial Shunt (Adona Medical)

Presenter: Paul Sorajja

October 26, 2023

Presentation TCT 2023

Balancing Residual MR and MS After Transcatheter Edge-to-Edge Repair

Presenter: Paul Sorajja

October 25, 2023

Presentation TCT 2023

Technological Feasibility Has Been Achieved, Further Iterations Will Continue to Improve Outcomes!

Presenter: Paul Sorajja

October 23, 2023

Presentation TVT 2023

Successful Treatment of Mitral Regurgitation Patient with Severe Mitral Annular Calcification who was Screen Failed From Multiple TMVR Technologies

Presenter: Paul Sorajja

June 10, 2023

Presentation TVT 2023

LATE BREAKING INNOVATION: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Comparing the TRILUMINATE™ Pivotal and bRIGHT Clinical Trials

Presenter: Paul Sorajja

June 09, 2023

Presentation TVT 2023

Lessons Learned from the TRILUMINATE Trial: Balancing the Safety and Efficacy of Transcatheter Tricuspid Valve Repair

Presenter: Paul Sorajja

June 08, 2023

Advertisement

Viewpoint 2: When to do T-TEER or TTVR

An Innovative Tricuspid Therapy: Introducing the TripairTM Technology (Coramaze)

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Electrosurgery Clip Removal Followed by TMVR

Viewpoint 2: When to do Tricuspid TEER

The TriPair Tricuspid Repair Solution (Coramaze)

Transcatheter Treatment After TEER — Lacerate or Remove?

YES, in these Desperate Patients, Quality-of-Life Outcomes Are a Great Starting Point!

Performance of Atrial-fixation TMVR in Patients With Mitral Regurgitation (MR) and Mitral Annular Calcification (MAC)

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

The Interventional Cardiologist’s Perspective: Which Primary MR Patients Should Be Referred For Surgery?

The Role of TMVR With Dedicated Devices in Patients With MAC: Initial Results and Ongoing Trials

Procedural Goals for TTVI - Is Moderate TR Good Enough?

Novel Technology to Enable Atrioventricular Valve Replacement After TEER Therapy (AMX Technologies) (68998)

Pre-Clinical Results With A Chronically-Adjustable And Pressure Sensing Interatrial Shunt (Adona Medical)

Balancing Residual MR and MS After Transcatheter Edge-to-Edge Repair

Technological Feasibility Has Been Achieved, Further Iterations Will Continue to Improve Outcomes!

Successful Treatment of Mitral Regurgitation Patient with Severe Mitral Annular Calcification who was Screen Failed From Multiple TMVR Technologies

LATE BREAKING INNOVATION: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Comparing the TRILUMINATE™ Pivotal and bRIGHT Clinical Trials

Lessons Learned from the TRILUMINATE Trial: Balancing the Safety and Efficacy of Transcatheter Tricuspid Valve Repair

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content